one
key
question
virolog
virus
encod
rel
gene
gain
temporari
constant
control
host
understand
pathogen
viru
import
gain
knowledg
function
individu
viral
protein
host
cell
interact
viral
cellular
protein
consequ
interact
cellular
signal
pathway
combin
transcriptom
proteom
highthroughput
technolog
bioinformat
analysi
respect
data
help
elucid
specif
cellular
antivir
drug
target
candid
addit
viral
human
interactom
analys
indic
differ
virus
target
common
central
human
protein
enter
cellular
signal
pathway
machineri
might
constitut
power
broadspectrum
antivir
target
yue
malauer
jian
lei
rolf
hilgenfeld
albrecht
von
brunn
one
key
question
virolog
virus
encod
rel
gene
gain
temporari
constant
control
host
understand
pathogen
viru
import
gain
knowledg
function
individu
viral
protein
host
cell
interact
viral
cellular
protein
consequ
interact
cellular
signal
pathway
combin
transcriptom
proteom
highthroughput
technolog
bioinformat
analysi
respect
data
help
elucid
specif
cellular
antivir
drug
target
candid
addit
viral
human
interactom
analys
indic
differ
virus
target
common
central
human
protein
enter
cellular
signal
pathway
machineri
might
constitut
power
broadspectrum
antivir
target
sinc
decad
research
struggl
discov
highli
effect
drug
broadrang
antivir
activ
nowaday
almost
antivir
drug
use
clinic
treatment
target
particular
virus
subunit
thereof
inhibitor
direct
specif
viral
protein
eg
proteas
replicas
revers
transcriptas
frequent
use
antivir
often
antivir
littl
broadrang
activ
howev
replic
cycl
virus
depend
viral
protein
well
host
cellular
cofactor
far
outnumb
viral
protein
therefor
import
studi
virushost
interact
identifi
key
cellular
cofactor
signal
pathway
commonli
need
differ
virus
drug
design
target
cofactor
signal
pathway
may
consid
broadrang
antivir
candid
furthermor
resist
cellular
target
expect
develop
rapidli
recent
year
combin
experiment
highthroughput
ht
technolog
bioinformat
allow
systemwid
studi
virushost
relat
level
transcriptom
metabolom
proteom
review
focu
proteinprotein
interact
ppi
one
strategi
studi
virushost
relat
first
give
brief
summari
method
use
studi
virushost
interact
describ
promin
exampl
genomewid
interact
studi
includ
structur
aspect
focu
specif
hostprotein
famili
immunophilin
necessari
replic
sever
virus
includ
coronavirus
protein
appear
suitabl
develop
broadrang
antivir
proteom
chang
studi
level
individu
virushost
protein
interact
organel
whole
cell
gel
electrophoresi
mass
spectrometri
ms
use
numer
studi
identifi
gene
express
pattern
infect
cell
method
variat
thereof
allow
identif
rel
quantif
comparison
abund
protein
infect
versu
noninfect
sampl
small
larg
hydrophob
lowabund
protein
difficult
resolv
drawback
frequent
limit
reproduc
lack
ht
capabl
mass
spectrometri
excel
mean
protein
identif
isobar
tag
techniqu
includ
stabl
isotop
label
amino
acid
silac
cell
cultur
allow
quantit
examin
virushost
cell
relat
improv
field
significantli
msbase
techniqu
recent
also
use
character
hostpathogen
interact
within
purifi
matur
viru
particl
includ
vaccinia
viru
influenza
viru
hiv
vesicular
stomat
viru
sarscorona
viru
sever
herp
virus
final
twohybridbas
mammalian
ppi
trap
mappit
drive
cellular
signal
cascad
endogen
transcript
report
use
ht
assay
hcv
protein
human
protein
interactom
analysi
yeast
twohybrid
popular
intens
use
altern
studi
virushost
proteinprotein
interact
global
proteom
scale
exploit
yeast
genet
engin
modular
eukaryot
transcript
factor
tf
util
dnabind
domain
dbd
activ
domain
ad
bait
protein
fuse
dbd
prey
protein
fuse
ad
reconstitut
function
tf
eg
yeast
upon
interact
fusion
protein
test
system
use
ht
manner
perform
arraybas
matrix
screen
eg
viru
protein
screen
individu
bait
viru
protein
cdna
prey
librari
differ
origin
former
allow
establish
intravir
latter
virushost
interactom
concept
virushost
interactom
studi
outlin
figur
limit
system
transcript
report
system
basi
nuclear
local
limit
analysi
hydrophob
membran
protein
possibl
disrupt
nuclear
membran
also
lack
mammalian
translat
modif
might
contribut
detect
rate
quarter
interact
estim
recent
studi
fals
posit
interact
drawback
effici
prevent
use
proper
control
thu
result
highqual
largescal
screen
increas
reliabl
decreas
falseneg
rate
recent
achiev
systemat
combin
screen
strategi
use
novel
ntermin
bait
ctermin
bait
prey
fusionprotein
vector
biolog
signific
address
valid
interact
differ
biochem
andor
mammalian
cellbas
method
coimmunoprecipit
success
appli
coproduc
protein
contain
short
fusion
tag
mammalian
cell
method
timeconsum
applic
smallscal
evalu
lumier
luminescencebas
mammalian
interactom
map
assay
modifi
version
thereof
pulldown
assay
bait
protein
use
fusion
flagtag
protein
prey
protein
use
fusion
luciferas
vice
versa
detect
method
well
protein
fragment
complement
assay
pca
splityfpbas
splitluciferasebas
method
well
suit
ht
screen
latter
two
assay
test
protein
fuse
subdomain
yfp
luciferas
upon
physic
interact
bait
prey
protein
respect
yfp
luciferas
fragment
reconstitut
fluoresc
enzymat
activ
respect
split
betalactamas
interact
assay
recent
describ
cellfre
test
screen
small
molecular
peptid
inhibitor
intrigu
fluoresc
twohybrid
assay
allow
direct
visual
analysi
ppi
singl
live
cell
util
stabl
nuclear
interact
platform
recent
year
sever
public
genomewid
genet
screen
hostcellular
cofactor
influenza
viru
hepat
c
viru
hcv
human
immunodefici
viru
hiv
sever
acut
respiratori
viru
sarscov
virus
field
influenza
viru
dsrna
sirna
screen
appli
select
host
gene
crucial
influenza
viru
infect
shaw
et
al
compar
result
screen
sort
major
select
cellular
cofactor
six
function
categori
gene
classif
cluster
ribosom
copi
vesicl
protontransport
vtype
atpas
complex
spliceosom
nuclear
poreenvelop
kinasesign
involv
ribosom
surpris
respons
catalyz
synthesi
protein
amino
acid
host
cell
also
virus
addit
influenza
viru
ribosom
demonstr
play
role
infect
virus
exampl
sarscov
nonstructur
protein
bind
ribosom
subunit
inactiv
translat
activ
subunit
induc
hostmrna
degrad
sarscovinfect
cell
vacuolartyp
h
atpas
vatpas
complex
acidifi
endosom
step
requir
fusion
viral
endosom
membran
result
subsequ
releas
viral
genom
cytosol
therebi
activ
vatpas
complex
theoret
import
entri
virus
take
advantag
host
cell
endocyt
machineri
sarscov
semliki
forest
viru
perhap
virus
enter
cell
via
direct
membran
fusion
import
nuclear
poreenvelopeassoci
protein
indic
previous
instanc
human
karyopherin
alpha
importin
alpha
interact
partner
sarscov
accessori
protein
hcv
nonstructur
protein
human
karyopherin
alpha
importin
alpha
interact
multipl
viral
pathogen
group
includ
sarscov
adenoviru
hiv
human
karyopherin
beta
form
heterodim
karyopherin
alpha
assist
import
protein
nuclear
local
signal
nl
found
five
influenza
screen
kinas
signal
broad
categori
categori
mitogenactiv
protein
kinas
mapk
signal
seem
play
import
role
influenza
viru
infect
also
hcv
infect
addit
phosphorylationmedi
jakstat
signal
regul
express
interferonstimul
gene
also
involv
respons
multipl
viral
pathogen
abund
kinas
signal
categori
provid
mani
druggabl
target
cdclike
kinas
inhibit
reduc
influenza
viru
replic
two
order
magnitud
natur
drug
target
viral
protein
tend
virusspecif
drug
direct
cellular
protein
signal
pathway
potenti
much
broader
spectrum
antivir
activ
differ
virus
may
requir
similar
cellular
function
replic
describ
sever
druggabl
cellular
protein
might
serv
antivir
target
variou
virus
especi
influenza
viru
systemat
survey
smallcompound
librari
antivir
activ
perform
util
highli
sophist
ht
methodolog
howev
case
influenza
viru
effici
antivir
approv
way
accordingli
virus
seem
share
host
protein
target
overtak
cellular
signal
pathway
machineri
might
constitut
attract
broadspectrum
antivir
target
sarscov
screen
identifi
immunophilin
broadspectrum
anticoronavir
target
approach
recent
use
success
coronaviru
field
unbias
hypothesisfre
screen
sarscovorfeom
includ
subfrag
thereof
test
human
cdna
librari
lead
identif
human
immunophilin
cyclophilin
protein
fkbp
gene
famili
prerequisit
viru
replic
respect
protein
known
mani
year
inhibit
immunosuppress
compound
cyclosporin
csa
interact
sarscov
protein
cyclophilin
ppia
ppig
ppih
fkbp
well
calcipressin
also
confirm
modifi
luminescencebas
mammalian
interactomemap
assay
eyecatch
particularli
regard
influenc
cellular
serin
phosphatas
calcineurin
cn
basi
wellknown
complex
format
cyclophilin
csa
two
import
issu
aros
pathogenesi
replic
sarscov
figur
show
influenc
cyclophilincsa
possibl
involv
sarscov
nfat
regul
viru
replic
regard
pathogen
induct
immunolog
import
cnnfat
nuclear
factor
activ
tcell
pathway
viru
viral
might
provid
possibl
explan
highli
disord
cytokin
level
cytokin
storm
sar
patient
howev
known
protein
influenc
nfat
induct
shown
csa
inhibit
replic
sarscov
also
two
human
coronavirus
anim
cov
felin
cov
fcov
transmiss
gastroenter
viru
tgev
pig
infecti
bronchiti
viru
ibv
bird
csa
inhibit
repres
three
cov
genera
alphacov
betacov
gammacov
might
thu
serv
pancoronaviru
inhibitor
gammacoronavirus
lack
highli
possibl
coronavir
protein
also
involv
interact
cyclophilin
interact
demonstr
vitro
sarscov
nucleocapsid
protein
mechan
inhibit
coronaviru
replic
csa
clear
reason
assum
howev
analog
hcv
peptidylcistran
isomeras
chaperon
activ
cyclophilin
block
csa
lead
improp
fold
viral
protein
case
crystal
structur
complex
cyclophilin
viral
capsid
protein
influenc
csa
sarscov
nfat
signal
viral
replic
ii
csa
interact
ppia
respect
complex
csappia
block
catalyt
domain
calcineurin
cn
therebi
inhibit
dephosphoryl
nfatc
transcript
factor
consequ
phosphoryl
nfatc
transloc
nucleu
induc
express
cytokin
also
interact
ryanodin
receptor
inositol
trisphosph
receptor
calcium
channel
er
membran
ad
result
calcium
releas
er
decreas
calcium
concentr
er
sens
stromal
interact
molecul
stim
subsequ
stim
activ
ca
releaseactiv
ca
channel
crac
via
proteinprotein
interact
plasma
membran
result
ca
influx
extracellular
space
ca
influx
requir
activ
cn
calcium
sensor
calmodulin
cam
sarscov
bind
cn
observ
unpublish
viru
infect
overexpress
induc
nfat
activ
vitro
block
presenc
csa
ii
bind
ppia
csa
bind
ppia
bind
inhibit
coronavir
replic
cell
cultur
probabl
interrupt
format
complex
ca
avail
flexibl
loop
helix
alpha
helic
turn
alpha
ca
bind
activ
groov
cyclophilin
figur
interestingli
conform
cyclophilin
complex
ca
similar
free
enzym
complex
csa
ligand
thu
cyclophilin
appear
rigid
scaffold
protein
fact
facilit
structurebas
design
compound
compet
ca
bind
seri
thiourea
compound
design
inhibitor
target
interact
shown
block
replic
also
interact
vpr
cyclophilin
demonstr
csa
also
exert
inhibitori
effect
vaccinia
viru
bk
polyoma
viru
influenza
viru
cyclophilin
adepend
cyclophilin
aindepend
pathway
also
inhibit
human
cov
sarscov
found
inhibitori
effect
chronic
newli
cell
mgml
replic
replicon
hcv
rna
concentr
mgml
also
affect
orthopoxvirus
howev
inhibit
antiimmunophilin
drug
promis
antivir
candid
howev
sever
immunosuppress
side
effect
normal
undesir
overcom
develop
nonimmmunosuppress
deriv
drug
still
display
antivir
activ
destroy
calcineurinbind
site
preserv
cyclophilinbind
activ
promis
exampl
csa
deriv
demonstr
inhibit
hcv
replic
effici
integr
viral
orfeom
databas
design
gener
versatil
collect
viral
orf
viral
virushost
protein
interact
databas
extrem
valuabl
tool
comparison
analysi
increas
sever
viru
interactom
well
individu
protein
intravir
virushost
level
sever
assay
avail
studi
virushost
relat
carri
intrins
advantag
disadvantag
techniqu
address
interact
protein
rna
level
might
promis
respect
inhibitor
identif
exampl
role
play
posttranscript
modif
inde
screen
sarscovorfeom
human
cdna
librari
identifi
member
cyclophilin
fkbp
protein
famili
prerequisit
coronaviru
replic
interact
sarscov
protein
cellular
protein
led
discoveri
natur
cyclophilin
ligand
csa
inhibitor
anim
human
coronavirus
pancoronaviru
inhibitor
natur
fkbpligand
inhibitor
human
coronavirus
second
independ
aspect
interact
discoveri
upregul
immunolog
import
cn
nfat
signal
pathway
sarscov
viru
might
provid
explan
socal
cytokin
storm
sar
patient
technic
point
view
may
note
describ
interact
occur
low
abund
screen
relev
cellular
protein
famili
coronaviru
biolog
first
realiz
care
eye
inspect
contempl
interact
data
keep
relat
literatur
mind
construct
larg
color
interact
map
per
se
necessarili
give
hint
relev
cellular
target
molecul
signal
pathway
antivir
therapi
undoubtedli
interact
databas
databas
special
drug
target
ppi
ppiinhibit
small
molecul
integr
system
assess
druggabl
ppi
provid
invalu
computer
tool
develop
antivir
futur
paper
particular
interest
publish
within
period
review
highlight
special
interest
outstand
interest
antivir
resist
cartoon
view
cyclophilin
cyan
capsid
yellow
complex
structur
pdb
id
bind
site
csa
overlap
loop
red
connect
alpha
helix
helic
turn
alpha
ca
bind
activ
groov
cyclophilin
